Wolverine Trading, LLC Reata Pharmaceuticals Inc Call Options Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 23, 2023	BUY	$79.22 - $105.37 $4.33 Million - $5.76 Million	54,700 Added 408.21%	68,100 $6.94 Million
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $413,390 - $1.25 Million	13,400 New	13,400 $1.21 Million
Q1 2020 May 11, 2020	SELL	$124.16 - $247.74 $869,120 - $1.73 Million	-7,000 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$74.57 - $217.92 $596,560 - $1.74 Million	-8,000 Reduced 53.33%	7,000 $1.43 Million
Q3 2019 Nov 14, 2019	BUY	$71.26 - $95.75 $712,600 - $957,500	10,000 Added 200.0%	15,000 $1.26 Million
Q1 2019 May 15, 2019	BUY	$51.9 - $101.79 $259,500 - $508,950	5,000 New	5,000 $427,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.